Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 9, Issue 6, pp. 1618-1628
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 13, 2010
- Accepted March 12, 2010
- Published first June 8, 2010.
Article Versions
- Previous version (June 8, 2010 - 10:02).
- You are viewing the most recent version of this article.
Copyright & Usage
©2010 American Association for Cancer Research.
Author Information
- Ping Wei1,
- Marlena Walls1,
- Ming Qiu1,
- Richard Ding1,
- Robert H. Denlinger2,
- Anthony Wong2,
- Kosta Tsaparikos1,
- Jitesh P. Jani1,
- Natilie Hosea3,
- Michelle Sands3,
- Sophia Randolph4 and
- Tod Smeal1
- Authors' Affiliations: 1Drug Discovery Group and Oncology Research Unit, 2Drug Safety Research and Development, 3Pharmacokinetics, Dynamics and Metabolism, and 4Translational Medicine Group and Oncology Business Unit, Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California
- Corresponding Author:
Tod Smeal, Oncology Research Unit, Pfizer Global Research and Development, La Jolla Laboratories, 10724 Science Center Drive, La Jolla, CA 92121. Phone: 858-622-8081; Fax: 858-526-4121. E-mail: tod.smeal{at}pfizer.com
June 2010
Volume 9, Issue 6
Volume 9, Issue 6
Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design
Jump to section
Advertisement